Suppr超能文献

锝-99m 甲氧基异丁基异腈闪烁扫描术与超声在甲状旁腺腺瘤和甲状旁腺增生诊断中的比较。

Comparison between technetium-99m methoxyisobutylisonitrile scintigraphy and ultrasound in the diagnosis of parathyroid adenoma and parathyroid hyperplasia.

作者信息

Xue Jianjun, Liu Yan, Ji Ting, Zhao Aomei, Liang Yiqian, Deng Huixing, Wang Qi, Zhang Yuemin, Yang Lulu, Yang Aimin

出版信息

Nucl Med Commun. 2018 Dec;39(12):1129-1137. doi: 10.1097/MNM.0000000000000921.

Abstract

OBJECTIVE

The aim of this study was to evaluate the value of technetium-99m methoxyisobutylisonitrile (Tc-MIBI) imaging and ultrasound in preoperative localization of parathyroid adenoma (PA) and parathyroid hyperplasia (PH).

PARTICIPANTS AND METHODS

A retrospective study of Tc-MIBI double-phase scintigraphy (DPS) was performed in 187 hyperparathyroidism cases with pathologically diagnosed PA or PH. Of these patients, 167 cases underwent ultrasound, and 146 cases underwent Tc-MIBI single-photon emission computed tomography/computed tomography (SPECT/CT). The sensitivity and diagnostic accuracy of ultrasound, Tc-MIBI DPS, and SPECT/CT were compared between PA and PH. Differences in Tc-MIBI DPS, serum parathyroid hormone (PTH), serum calcium and phosphorus, as well as the weight and longest diameter of lesion between PA and PH were also compared.

RESULTS

As per patient-based analysis, the sensitivity of ultrasound, Tc-MIBI DPS, and SPECT/CT was 90.70% (39/43), 95.56% (43/45), and 100.00% (30/30), respectively, for PA, and 93.55% (116/124), 90.85% (129/142), and 93.10% (108/116), respectively, for PH. There were no significant differences in sensitivity of these three imaging methods between PA and PH. However, per lesion-based analysis, the accuracy of ultrasound, Tc-MIBI DPS, and SPECT/CT in detecting PA was 78.43% (40/51), 86.79% (46/53) and 96.88% (31/32), respectively, and the accuracy of Tc-MIBI DPS was higher than that of ultrasound (χ=6.507, P=0.011), and for PH, it was 49.69% (160/322), 40.71% (171/420), and 43.80% (152/347), respectively. The accuracy of ultrasound was higher than that of Tc-MIBI DPS (χ=5.940, P=0.015). The accuracy of a combination of all three examinations of ultrasound+Tc-MIBI DPS, ultrasound+Tc-MIBI SPECT/CT, Tc-MIBI DPS+SPECT/CT, and ultrasound+Tc-MIBI DPS+Tc-MIBI SPECT/CT was 51.51% (154/299), 53.85% (161/299), 50.17% (150/299), and 54.18% (162/299), respectively, which was higher than that of ultrasound (χ=5.273, P=0.022; χ=8.226, P=0.004; χ=3.880, P=0.049; χ=8.702, P=0.003, respectively). Serum levels of PTH and phosphorus were lower in patients with PA than in patients with PH (P<0.001), and serum calcium level, the weight, and the longest diameter of lesion and early uptake rate of Tc-MIBI DPS were higher in patients with PA than in patients with PH (P<0.01). Serum PTH level is often less than 1000 pg/ml in PA, but usually more than 1000 pg/ml in PH.

CONCLUSION

Ultrasound, Tc-MIBI DPS, and SPECT/CT all have a higher value in the diagnosis of PA than PH. Tc-MIBI SPECT/CT should be optimal for detecting PA, and early SPECT/CT scan might be better than delayed scan. Compared with Tc-MIBI DPS and SPECT/CT, ultrasound has a slight advantage in localization of PH lesions. The combination of ultrasound and Tc-MIBI DPS or SPECT/CT imaging could improve the accuracy in localization of PH lesions and should be considered as the first-line method for detecting PH.

摘要

目的

本研究旨在评估锝-99m甲氧基异丁基异腈(Tc-MIBI)显像及超声检查在甲状旁腺腺瘤(PA)和甲状旁腺增生(PH)术前定位中的价值。

参与者与方法

对187例经病理诊断为PA或PH的甲状旁腺功能亢进患者进行Tc-MIBI双时相闪烁显像(DPS)的回顾性研究。其中167例患者接受了超声检查,146例患者接受了Tc-MIBI单光子发射计算机断层扫描/计算机断层扫描(SPECT/CT)。比较了PA和PH患者中超声、Tc-MIBI DPS及SPECT/CT的敏感性和诊断准确性。还比较了PA和PH患者在Tc-MIBI DPS、血清甲状旁腺激素(PTH)、血清钙和磷水平,以及病变的重量和最长径之间的差异。

结果

基于患者的分析,对于PA,超声、Tc-MIBI DPS及SPECT/CT的敏感性分别为90.70%(39/43)、95.56%(43/45)和100.00%(30/30);对于PH,敏感性分别为93.55%(116/124)、90.85%(129/142)和93.10%(108/116)。PA和PH患者中这三种成像方法的敏感性无显著差异。然而,基于病灶的分析,超声、Tc-MIBI DPS及SPECT/CT检测PA的准确性分别为78.43%(40/51)、86.79%(46/53)和96.88%(31/32),Tc-MIBI DPS的准确性高于超声(χ=6.507,P=0.011);对于PH,准确性分别为49.69%(160/322)、40.71%(171/??420)和43.80%(152/347),超声的准确性高于Tc-MIBI DPS(χ=5.940,P=0.015)。超声+Tc-MIBI DPS、超声+Tc-MIBI SPECT/CT、Tc-MIBI DPS+SPECT/CT及超声+Tc-MIBI DPS+Tc-MIBI SPECT/CT这四种联合检查的准确性分别为51.51%(154/299)、53.85%(161/299)、50.17%(150/299)和54.18%(162/299),均高于超声(χ值及P值分别为χ=5.273,P=0.022;χ=8.226,P=0.004;χ=3.880,P=0.049;χ=8.702,P=0.003)。PA患者的血清PTH和磷水平低于PH患者(P<0.001),PA患者的血清钙水平、病变重量、最长径及Tc-MIBI DPS的早期摄取率高于PH患者(P<0.01)。PA患者的血清PTH水平通常低于1000 pg/ml,而PH患者通常高于1000 pg/ml。

结论

超声、Tc-MIBI DPS及SPECT/CT在PA诊断中的价值均高于PH。Tc-MIBI SPECT/CT应是检测PA的最佳方法,早期SPECT/CT扫描可能优于延迟扫描。与Tc-MIBI DPS和SPECT/CT相比,超声在PH病灶定位方面具有轻微优势。超声与Tc-MIBI DPS或SPECT/CT成像联合应用可提高PH病灶定位的准确性,应作为检测PH的一线方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/294a/6254783/d4947e6d2848/mnm-39-1129-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验